These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors. Łegowska A; Debowski D; Lesner A; Wysocka M; Rolka K Bioorg Med Chem; 2009 May; 17(9):3302-7. PubMed ID: 19362846 [TBL] [Abstract][Full Text] [Related]
11. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin. Lin J; Cassidy CS; Frey PA Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318 [TBL] [Abstract][Full Text] [Related]
12. The anti-leishmanial activity of dipeptide esters on Leishmania amazonensis amastigotes. Ramazeilles C; Juliano L; Chagas JR; Rabinovitch M Parasitology; 1990 Apr; 100 Pt 2():201-7. PubMed ID: 2345655 [TBL] [Abstract][Full Text] [Related]
13. Conformation of the primary binding loop folded through an intramolecular interaction contributes to the strong chymotrypsin inhibitory activity of the chymotrypsin inhibitor from Erythrina variegata seeds. Iwanaga S; Nagata R; Miyamoto A; Kouzuma Y; Yamasaki N; Kimura M J Biochem; 1999 Jul; 126(1):162-7. PubMed ID: 10393334 [TBL] [Abstract][Full Text] [Related]
14. Designing of substrates and inhibitors of bovine alpha-chymotrypsin with synthetic phenylalanine analogues in position P(1). Wysocka M; Lesner A; Legowska A; Jaśkiewicz A; Miecznikowska H; Rolka K Protein Pept Lett; 2008; 15(3):260-4. PubMed ID: 18336354 [TBL] [Abstract][Full Text] [Related]
15. Interaction of ferrocenoyl-dipeptides with 3-aminopyrazole derivatives: beta-sheet models? A synthetic, spectroscopic, structural, and electrochemical study. Saweczko P; Enright GD; Kraatz HB Inorg Chem; 2001 Aug; 40(17):4409-19. PubMed ID: 11487349 [TBL] [Abstract][Full Text] [Related]
16. Derivatives of melphalan designed to enhance drug accumulation in cancer cells. Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of chymotrypsin by peptidyl trifluoromethyl ketones: determinants of slow-binding kinetics. Brady K; Abeles RH Biochemistry; 1990 Aug; 29(33):7608-17. PubMed ID: 2271521 [TBL] [Abstract][Full Text] [Related]
18. Extended binding inhibitors of chymotrypsin that interact with leaving group subsites S1'-S3'. Imperiali B; Abeles RH Biochemistry; 1987 Jul; 26(14):4474-7. PubMed ID: 3663602 [TBL] [Abstract][Full Text] [Related]
19. Kinetic study of alpha-chymotrypsin catalysis with regard to the interaction between the specificity-determining site and the aromatic side chain of substrates. Ohno M; Sato S; Karasaki Y; Tsukamoto S J Biochem; 1976 Aug; 80(2):239-51. PubMed ID: 1002668 [TBL] [Abstract][Full Text] [Related]